Taiko Pharmaceutical Co., Ltd.'s total assets for Q4 2024 were ¥12.91B, a decrease of -1.70% from the previous quarter. JP:4574 total liabilities were ¥4.95B for the fiscal quarter, a -2.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.